Across TCGA cell cohorts, ABHD16A mutation is significantly associated with the RNA expression of many other genes, with 14 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible ABHD16A-associated genes across cancer lineages are SLC32A1, PHOX2B, and FUT5. Each is linked with ABHD16A in more than 1 cancer types. Because this analysis shows association rather than direction, both ABHD16A-to-partner and partner-to-ABHD16A results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ABHD16A→partner) and Y-score (partner→ABHD16A) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLOOD_Leukemia	SLC32A1 →	+0.753	+3.223	<.001	.004	3	1
BLOOD_Leukemia	PHOX2B →	+0.020	+3.687	<.001	<.001	3	1
BLOOD_Leukemia	FUT5 →	+0.231	+3.681	<.001	.005	3	1
BLOOD_Leukemia	TMEM95 →	+0.020	+3.269	<.001	.007	3	1
BLOOD_Leukemia	TCEAL2 →	+0.487	+4.354	.009	<.001	3	1
BLOOD_Leukemia	KPNA7 →	+0.364	+2.906	<.001	.009	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 14 associations by consensus.

Exploration

ABHD16A survival (RNA) · tumor vs normal (RNA) · all ABHD16A data types